STAT3 and neoplasm: Shen et al. observed that in a human liver cancer cell line and in tumour tissue, HAMP downregulation caused increments in components of the cyclin-dependent kinase-1/STAT3 (CDK1/STAT3) pathway, namely, CDK1, STAT3 and phospho-STAT3 [63].